![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 16
2022
Berger, Michael; Seemueller, Florian; Voggt, Alessandra; Obermeier, Michael; Kirchberg, Franca; Loew, Anja; Riedel, Michael; Schacky, Clemens von und Severus, Emanuel
(2022):
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: theBIPO-3 trial.
In: International Journal of Bipolar Disorders, Bd. 10, Nr. 1, 9
2021
Fischer, Kai F.; Simon, Maria S.; Elsner, Julie; Dobmeier, Johanna; Dorr, Johannes; Blei, Leonie; Zill, Peter; Obermeier, Michael und Musil, Richard
(2021):
Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders.
In: European archives of psychiatry and clinical neuroscience, Bd. 271: S. 1331-1341
[PDF, 2MB]
Fischer, Kai F.; Simon, Maria S.; Elsner, Julie; Dobmeier, Johanna; Dorr, Johannes; Blei, Leonie; Zill, Peter; Obermeier, Michael und Musil, Richard
(2021):
Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 271, Nr. 7: S. 1331-1341
2020
Schennach, Rebecca; Riedel, Michael; Obermeier, Michael; Jaeger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkoetter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Ruether, Eckart; Klingberg, Stefan; Gastpar, Markus; Seemueller, Florian; Spellmann, Ilja; Musil, Richard und Moeller, Hans-Jürgen
(2020):
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 6: S. 661-671
Barton, Barbara B.; Segger, Felix; Fischer, Kai; Obermeier, Michael und Musil, Richard
(2020):
Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis.
In: Expert Opinion on Drug Safety, Bd. 19, Nr. 3: S. 295-314
2019
Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jaeger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd und Moeller, Hans-Jürgen
(2019):
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
In: Pharmacopsychiatry, Bd. 52, Nr. 4: S. 180-185
Schennach, Rebecca; Obermeier, Michael; Spellmann, Ilja; Seemüller, Florian; Musil, Richard; Jaeger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkoetter, Joachim; Heuser, Isabella; Bauer, Michael; Adli, Mazda; Zeiler, Joachim; Bender, Wolfram; Kronmüller, Klaus-Thomas; Ising, Marcus; Brieger, Peter; Maier, Wolfgang; Lemke, Matthias R.; Ruether, Eckart; Klingberg, Stefan; Gastpar, Markus; Moeller, Hans-Jürgen und Riedel, Michael
(2019):
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.
In: Schizophrenia Research, Bd. 209: S. 185-192
2018
Spellmann, Ilja; Reinhard, Matthias A.; Veverka, Diana; Zill, Peter; Obermeier, Michael; Dehning, Sandra; Schennach, Rebecca; Müller, Norbert; Möller, Hans-Jürgen; Riedel, Michael und Musil, Richard
(2018):
QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 268, Nr. 4: S. 383-390
2017
Schennach, Rebecca; Obermeier, Michael; Seemüller, Florian; Jäger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gäbel, Wolfgang; Klosterköter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Spellmann, Ilja; Musil, Richard; Möller, Hans-Jürgen und Riedel, Michael
(2017):
Add-on Antidepressants in the Naturalistic Treatment of - Schizophrenia Spectrum Disorder - When, Who, and How?
In: Pharmacopsychiatry, Bd. 50, Nr. 4: S. 136-144
Spellmann, Ilja; Riedel, Michael; Städtler, Julia; Zill, Peter; Obermeier, Michael; Cerovecki, Anja; Dehning, Sandra; Schennach, Rebecca; Epple, Maria; Opgen-Rhein, Markus; Müller, Norbert; Bondy, Brigitta; Möller, Hans-Jürgen und Musil, Richard
(2017):
Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment.
In: Cognitive Neuropsychiatry, Bd. 22, Nr. 4: S. 280-297
2016
Seemüller, Florian; Obermeier, Michael; Schennach, Rebecca; Bauer, Michael; Adli, Mazda; Brieger, Peter; Laux, Gerd; Riedel, Michael; Falkai, Peter 
ORCID: https://orcid.org/0000-0003-2873-8667 und Möller, Hans-Jürgen
(2016):
Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.
In: BMC Psychiatry
16:153
[PDF, 717kB]
ORCID: https://orcid.org/0000-0003-2873-8667 und Möller, Hans-Jürgen
(2016):
Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.
In: BMC Psychiatry
16:153
[PDF, 717kB]
Schennach, Rebecca; Möller, Hans-Jürgen; Obermeier, Michael; Seemüller, Florian; Jäger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkötter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Musil, Richard; Spellmann, Ilja und Riedel, Michael
(2016):
Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.
In: International Journal of Methods In Psychiatric Research, Bd. 25, Nr. 1: S. 3-11
Jobst, Andrea; Krause, Daniela; Maiwald, Carina; Härtl, Kristin; Myint, Aye-Mu; Kästner, Ralph; Obermeier, Michael; Padberg, Frank; Brücklmeier, Benedikt; Weidinger, Elif; Kieper, Susann; Schwarz, Markus; Zill, Peter und Müller, Norbert
(2016):
Oxytocin course over pregnancy and postpartum period and the association with postpartum depressive symptoms.
In: Archives of Womens Mental Health, Bd. 19, Nr. 4: S. 571-579
2012
Schennach, Rebecca; Obermeier, Michael; Seemüller, Florian; Jäger, Markus; Schmauss, Max; Laux, Gerd; Pfeiffer, Herbert; Naber, Dieter; Schmidt, Lutz G.; Gaebel, Wolfgang; Klosterkötter, Joachim; Heuser, Isabella; Maier, Wolfgang; Lemke, Matthias R.; Rüther, Eckart; Klingberg, Stefan; Gastpar, Markus; Riedel, Michael und Möller, Hans-Jürgen
(2012):
Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
In: Psychopathology, Nr. 5: S. 276-285
[PDF, 245kB]
2011
Obermeier, Michael; Schennach-Wolff, Rebecca; Meyer, Sebastian; Moeller, Hans-Juergen; Riedel, Michael; Krause, Daniela und Seemueller, Florian
(2011):
Is the PANSS used correctly? a systematic review.
In: BMC Psychiatry
11:113
[PDF, 186kB]
2010
Seemüller, Florian; Möller, Hans-Jürgen; Obermeier, Michael; Schennach-Wolff, Rebecca und Riedel, Michael
(2010):
Review: antidepressants associated
with increased risk of suicidality in
adults aged less than 25 years.
In: Evidence-Based Mental Health, Bd. 13, Nr. 2: S. 52
[PDF, 90kB]